Details for Patent: 10,323,001
✉ Email this page to a colleague
Which drugs does patent 10,323,001 protect, and when does it expire?
Patent 10,323,001 protects KLISYRI and is included in one NDA.
This patent has thirty-four patent family members in thirteen countries.
Summary for Patent: 10,323,001
Title: | Compositions for modulating a kinase cascade and methods of use thereof |
Abstract: | The invention relates to compositions comprising 2-(5-(4-(2-morpholinoethoxy)phenyl) pyridin-2-yl)-N-benzylacetamide and its mesylate and dihydrochloride salts. The invention provides an efficient process for the synthesis of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide and its mesylate and dihydrochloride salts and methods for modulating one or more components of a kinase cascade using the compositions of the invention. The present invention also provides a novel polymorph of the mesylate salt of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide (Form A), characterized by a unique X-ray diffraction pattern and Differential Scanning Calorimetry profile, as well as a unique crystalline structure. |
Inventor(s): | Hangauer, Jr.; David G. (Lancaster, NY), Patra; Debasis (Manlius, NY), Cody; Jeremy A. (Clifton Springs, NY), Palmer; Grant J. (Nashville, TN), Isbester; Paul K. (Castleton on Hudson, NY), Salsbury; Jonathon (Madison, WI) |
Assignee: | Athenex, Inc. (Buffalo, NY) |
Application Number: | 15/387,322 |
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 10,323,001
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Almirall | KLISYRI | tirbanibulin | OINTMENT;TOPICAL | 213189-001 | Dec 14, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,323,001
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2007340350 | ⤷ Try a Trial | |||
Australia | 2008254500 | ⤷ Try a Trial | |||
Canada | 2673974 | ⤷ Try a Trial | |||
Canada | 2686267 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |